Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10Q

In layman's terms, if the court finds in favor of PTSC and we get a summary judgement, preferred shares will likely be issued to the BOD and they will run with the money...

I wonder how many shares they would award to Leckrook???

Share
New Message
Please login to post a reply